Long-term Study of Semapimod (CNI-1493) for Treatment of Crohn's Disease

Clinical trial NCT00740103 · COMPLETED

Trial details

NCT number: NCT00740103
Sponsor: Ferring Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2002-12-01
Primary completion: 2004-07-01
Enrollment: 119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.